Lawrence Schachner, MD discusses clinical pearls on the diagnosis and treatment of pediatric AD, including:

• How do we make sure that we correctly diagnose atopic dermatitis? What are some clinical pearls you can share for our audience?
• Since now dupilumab is approved for children with atopic dermatitis, what is its role and where would it fit into the “Schachner ladder”?
• How do crisaborole and dupilumab fit into the long-term care of AD? For how long should they be used?